Mcl‐1 and Bcl‐xL cooperatively maintain integrity of hepatocytes in developing and adult murine liver
暂无分享,去创建一个
L. Hennighausen | N. Hayashi | N. Hiramatsu | Xiao-Ming Yin | K. Ohkawa | A. Hosui | T. Kodama | H. Hikita | T. Tatsumi | T. Takehara | T. Kanto | S. Shimizu | T. Miyagi | H. Ishida | Wei Li | Satoshi Shimizu | Hayato Hikita
[1] Marcus Schuchmann,et al. Knockout of myeloid cell leukemia‐1 induces liver damage and increases apoptosis susceptibility of murine hepatocytes , 2009, Hepatology.
[2] J. Bruix,et al. Molecular targeted therapies in hepatocellular carcinoma , 2008, Hepatology.
[3] G. Gores,et al. Cellular and molecular mechanisms of liver injury. , 2008, Gastroenterology.
[4] A. Strasser,et al. The BCL-2 protein family: opposing activities that mediate cell death , 2008, Nature Reviews Molecular Cell Biology.
[5] L. Boscá,et al. Protection against Fas‐induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes , 2007, Hepatology.
[6] You-Wen He,et al. The antiapoptotic protein Mcl-1 is essential for the survival of neutrophils but not macrophages. , 2007, Blood.
[7] S. Wilhelm,et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. , 2006, Cancer research.
[8] P. Galle,et al. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction , 2006, BMC Cancer.
[9] G. Gores,et al. Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas‐induced murine liver injury by altering Bcl‐2 proteins , 2006, Hepatology.
[10] Xiao-Ming Yin. Bid, a BH3-only multi-functional molecule, is at the cross road of life and death. , 2006, Gene.
[11] M. Peck-Radosavljevic,et al. Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. , 2006, Journal of hepatology.
[12] P. Galle,et al. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. , 2006, International journal of oncology.
[13] K. Kaestner. The making of the liver: developmental competence in foregut endoderm and induction of the hepatogenic program. , 2005, Cell cycle.
[14] Takahiro Suzuki,et al. Hepatocyte-specific disruption of Bcl-xL leads to continuous hepatocyte apoptosis and liver fibrotic responses. , 2004, Gastroenterology.
[15] D. Zink,et al. Hepatocyte growth factor induces Mcl‐1 in primary human hepatocytes and inhibits CD95‐mediated apoptosis via Akt , 2004, Hepatology.
[16] Y. Tsujimoto. Cell death: regulation by the Bcl‐2 protein family , 2006 .
[17] T. Takehara,et al. Suppression of Bcl-xL deamidation in human hepatocellular carcinomas. , 2003, Cancer research.
[18] K. Schulze-Osthoff,et al. Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.
[19] J. Slack,et al. Differentiated properties of hepatocytes induced from pancreatic cells , 2002, Hepatology.
[20] S. Friedman,et al. Expression and role of Bcl‐xL in human hepatocellular carcinomas , 2001, Hepatology.
[21] S. Korsmeyer,et al. Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.
[22] L. Hennighausen,et al. Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. , 2000, Development.
[23] K. Roth,et al. Mcl-1 deficiency results in peri-implantation embryonic lethality. , 2000, Genes & development.
[24] N. Hayashi,et al. Interleukin 1beta protects mice from Fas-mediated hepatocyte apoptosis and death. , 1999, Gastroenterology.
[25] S. Korsmeyer,et al. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis , 1999, Nature.
[26] G. Gores,et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. , 1999, The Journal of clinical investigation.
[27] K. Nakayama,et al. Accelerated Neutrophil Apoptosis in Mice Lacking A1-a, a Subtype of the bcl-2–related A1 Gene , 1998, The Journal of experimental medicine.
[28] C. Print,et al. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[29] M. Peter,et al. Two CD95 (APO‐1/Fas) signaling pathways , 1998, The EMBO journal.
[30] M. Skinner,et al. Testicular degeneration in Bclw-deficient mice , 1998, Nature Genetics.
[31] al. et,et al. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice , 1995, Science.
[32] D. Loh,et al. Targeted disruption of Bcl-2 alpha beta in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[33] S. Korsmeyer,et al. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.
[34] K. Zaret,et al. Hepatocyte differentiation initiates during endodermal-mesenchymal interactions prior to liver formation. , 1991, Development.